<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>285(27)</volume><submitter>Fayyad-Kazan H</submitter><pubmed_abstract>Regulatory T cells (Tregs) play a key role in immune system homeostasis and tolerance to antigens, thereby preventing autoimmunity, and may be partly responsible for the lack of an appropriate immune response against tumor cells. Although not sufficient, a high expression of forkhead box P3 (FOXP3) is necessary for their suppressive function. Recent reports have shown that histones deacetylase inhibitors increased FOXP3 expression in T cells. We therefore decided to investigate in non-Tregs CD4-positive cells, the mechanisms by which an aspecific opening of the chromatin could lead to an increased FOXP3 expression. We focused on binding of potentially activating transcription factors to the promoter region of FOXP3 and on modifications in the five miRs constituting the Tregs signature. Val</pubmed_abstract><journal>The Journal of biological chemistry</journal><pagination>20481-91</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2898312</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Valproate treatment of human cord blood CD4-positive effector T cells confers on them the molecular profile (microRNA signature and FOXP3 expression) of natural regulatory CD4-positive cells through inhibition of histone deacetylase.</pubmed_title><pmcid>PMC2898312</pmcid><pubmed_authors>Badran H</pubmed_authors><pubmed_authors>Martiat P</pubmed_authors><pubmed_authors>Lewalle P</pubmed_authors><pubmed_authors>Salaun B</pubmed_authors><pubmed_authors>Merimi M</pubmed_authors><pubmed_authors>Ezzeddine M</pubmed_authors><pubmed_authors>Jebbawi F</pubmed_authors><pubmed_authors>Fayyad-Kazan H</pubmed_authors><pubmed_authors>Burny A</pubmed_authors><pubmed_authors>El Zein N</pubmed_authors><pubmed_authors>Rouas R</pubmed_authors><pubmed_authors>Romero P</pubmed_authors><pubmed_authors>Mourtada M</pubmed_authors><pubmed_authors>Badran B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Valproate treatment of human cord blood CD4-positive effector T cells confers on them the molecular profile (microRNA signature and FOXP3 expression) of natural regulatory CD4-positive cells through inhibition of histone deacetylase.</name><description>Regulatory T cells (Tregs) play a key role in immune system homeostasis and tolerance to antigens, thereby preventing autoimmunity, and may be partly responsible for the lack of an appropriate immune response against tumor cells. Although not sufficient, a high expression of forkhead box P3 (FOXP3) is necessary for their suppressive function. Recent reports have shown that histones deacetylase inhibitors increased FOXP3 expression in T cells. We therefore decided to investigate in non-Tregs CD4-positive cells, the mechanisms by which an aspecific opening of the chromatin could lead to an increased FOXP3 expression. We focused on binding of potentially activating transcription factors to the promoter region of FOXP3 and on modifications in the five miRs constituting the Tregs signature. Val</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Jul</publication><modification>2025-04-03T22:11:31.972Z</modification><creation>2019-03-27T00:32:12Z</creation></dates><accession>S-EPMC2898312</accession><cross_references><pubmed>20427269</pubmed><doi>10.1074/jbc.M110.119628</doi><doi>10.1074/jbc.m110.119628</doi></cross_references></HashMap>